Skip to main content
scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · IEX Real-Time Price · USD
4.940
-0.040 (-0.80%)
At close: Jul 26, 2024, 4:00 PM
4.700
-0.240 (-4.86%)
After-hours: Jul 26, 2024, 7:25 PM EDT

scPharmaceuticals Revenue

scPharmaceuticals had revenue of $6.10M in the quarter ending March 31, 2024, with 195.78% growth. This brings the company's revenue in the last twelve months to $17.63M, up 754.68% year-over-year. In the year 2023, scPharmaceuticals had annual revenue of $13.59M.

Revenue (ttm)
$17.63M
Revenue Growth
+754.68%
P/S Ratio
10.10
Revenue / Employee
$130,607
Employees
135
Market Cap
178.11M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202313.59M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TruBridge 336.45M
Puma Biotechnology 226.63M
Personalis 74.15M
Fennec Pharmaceuticals 44.95M
MediWound 19.85M
Sangamo Therapeutics 18.76M
Revenue Rankings

SCPH News

More News